[go: up one dir, main page]

IL129530A - Acellular pertussis vaccine with diphtheria and tetanus-toxoids - Google Patents

Acellular pertussis vaccine with diphtheria and tetanus-toxoids

Info

Publication number
IL129530A
IL129530A IL12953097A IL12953097A IL129530A IL 129530 A IL129530 A IL 129530A IL 12953097 A IL12953097 A IL 12953097A IL 12953097 A IL12953097 A IL 12953097A IL 129530 A IL129530 A IL 129530A
Authority
IL
Israel
Prior art keywords
toxoids
tetanus
diphtheria
pertussis vaccine
acellular pertussis
Prior art date
Application number
IL12953097A
Other languages
English (en)
Other versions
IL129530A0 (en
Original Assignee
Smithkline Beecham Biolog
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Biolog filed Critical Smithkline Beecham Biolog
Publication of IL129530A0 publication Critical patent/IL129530A0/xx
Publication of IL129530A publication Critical patent/IL129530A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/08—Clostridium, e.g. Clostridium tetani
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0016—Combination vaccines based on diphtheria-tetanus-pertussis
    • A61K39/0018—Combination vaccines based on acellular diphtheria-tetanus-pertussis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/05—Actinobacteria, e.g. Actinomyces, Streptomyces, Nocardia, Bifidobacterium, Gardnerella, Corynebacterium; Propionibacterium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/099—Bordetella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K2039/10—Brucella; Bordetella, e.g. Bordetella pertussis; Not used, see subgroups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
IL12953097A 1996-11-07 1997-11-04 Acellular pertussis vaccine with diphtheria and tetanus-toxoids IL129530A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9623233.5A GB9623233D0 (en) 1996-11-07 1996-11-07 Vaccine composition
PCT/EP1997/006180 WO1998019702A1 (en) 1996-11-07 1997-11-04 Acellular pertussis vaccine with diphthriae- and tetanus-toxoids

Publications (2)

Publication Number Publication Date
IL129530A0 IL129530A0 (en) 2000-02-29
IL129530A true IL129530A (en) 2005-11-20

Family

ID=10802615

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12953097A IL129530A (en) 1996-11-07 1997-11-04 Acellular pertussis vaccine with diphtheria and tetanus-toxoids

Country Status (30)

Country Link
EP (2) EP1240905B3 (de)
JP (1) JP3980652B2 (de)
KR (1) KR100518044B1 (de)
CN (1) CN1130226C (de)
AR (1) AR011509A1 (de)
AT (2) ATE222773T1 (de)
AU (1) AU710475B2 (de)
BR (2) BRPI9712917B8 (de)
CA (1) CA2271008C (de)
CO (1) CO4910171A1 (de)
CY (2) CY2407B1 (de)
CZ (1) CZ295954B6 (de)
DE (3) DE69733285T3 (de)
DK (2) DK0941117T3 (de)
ES (2) ES2182131T3 (de)
GB (1) GB9623233D0 (de)
HK (1) HK1050473B (de)
HU (1) HU224126B1 (de)
IL (1) IL129530A (de)
LU (1) LU91183I2 (de)
NO (2) NO320186B1 (de)
NZ (1) NZ335384A (de)
PL (1) PL188460B1 (de)
PT (2) PT1240905E (de)
SA (1) SA98181128B1 (de)
SI (2) SI0941117T1 (de)
TR (1) TR199900979T2 (de)
TW (1) TW471971B (de)
WO (1) WO1998019702A1 (de)
ZA (1) ZA979984B (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1004314A1 (de) * 1998-11-26 2000-05-31 Pasteur Merieux MSD T.d.Polio Impstoff für einer primovakzinierter oder empfindlicher Population
KR100374813B1 (ko) * 2000-04-07 2003-03-03 녹십자백신 주식회사 디프테리아, 파상풍 톡소이드, 정제백일해 및비형간염표면항원을 포함한 4가 혼합백신 및 그 제조 방법
GB0108364D0 (en) * 2001-04-03 2001-05-23 Glaxosmithkline Biolog Sa Vaccine composition
KR100401423B1 (ko) * 2001-01-10 2003-10-17 주식회사 엘지생명과학 혼합 백신의 제조 방법
JP5007425B2 (ja) * 2006-01-30 2012-08-22 財団法人ヒューマンサイエンス振興財団 百日咳ワクチンの安全性評価方法
GB0616306D0 (en) * 2006-08-16 2006-09-27 Novartis Ag Vaccines
GB0822633D0 (en) * 2008-12-11 2009-01-21 Novartis Ag Formulation
US9950062B2 (en) 2009-09-02 2018-04-24 Glaxosmithkline Biologicals Sa Compounds and compositions as TLR activity modulators
CN103313725B (zh) 2010-09-01 2016-06-29 诺华有限公司 免疫增强剂吸附不溶性金属离子
CA2828844C (en) 2011-03-02 2020-07-14 Novartis Ag Combination vaccines with lower doses of antigen and/or adjuvant
CN102363041A (zh) * 2011-11-17 2012-02-29 成都欧林生物科技股份有限公司 不含防腐剂疫苗的制作工艺
MX372965B (es) * 2012-03-08 2020-04-01 Glaxosmithkline Biologicals Sa Formulaciones adyuvadas de vacunas de difteria, tetanos y tos ferina (dtp) de refuerzo.
CN102793915B (zh) * 2012-07-25 2013-10-23 天津康希诺生物技术有限公司 一种无细胞百日咳疫苗的生产方法
AU2013301312A1 (en) 2012-08-06 2015-03-19 Glaxosmithkline Biologicals S.A. Method for eliciting in infants an immune response against RSV and B. pertussis
US20140037680A1 (en) 2012-08-06 2014-02-06 Glaxosmithkline Biologicals, S.A. Novel method
CN103100081A (zh) * 2012-12-26 2013-05-15 天津康希诺生物技术有限公司 一种多价联合疫苗
EP2863943B1 (de) 2013-03-08 2016-07-13 Crucell Holland B.V. Nicht zellulärer pertussis-impfstoff
KR20160040290A (ko) 2013-08-05 2016-04-12 글락소스미스클라인 바이오로지칼즈 에스.에이. 조합 면역원성 조성물
CN114748616A (zh) * 2022-05-23 2022-07-15 中国医学科学院医学生物学研究所 一种成人青少年用无细胞百白破联合疫苗及其制备方法
CN117417419B (zh) * 2023-01-10 2024-04-19 康希诺生物股份公司 一种百日咳毒素脱毒方法及无细胞百白破联合疫苗
CN119524117B (zh) * 2025-01-23 2025-09-23 康希诺生物股份公司 免疫原性组合物、百白破联合疫苗及其制备方法和应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI861417A0 (fi) 1985-04-15 1986-04-01 Endotronics Inc Hepatitis b ytantigen framstaelld med rekombinant-dna-teknik, vaccin, diagnostiskt medel och cellinjer samt foerfaranden foer framstaellning daerav.
US4895800A (en) 1985-11-26 1990-01-23 Phillips Petroleum Company Yeast production of hepatitis B surface antigen
ZA88488B (en) 1987-01-30 1988-10-26 Smith Kline Rit Hepatitis b virus surface antigens and hybrid antigens containing them
EP1088830A3 (de) 1987-06-22 2004-04-07 Medeva Holdings B.V. Partikel von Hepatitis B Oberflächenantigen
DE3789866T2 (de) 1987-07-17 1994-09-22 Rhein Biotech Gesellschaft Fuer Neue Biotechnologische Prozesse Und Produkte Mbh, 40595 Duesseldorf DNA-Moleküle, die für FMDH-Kontrollabschnitte und Strukturgene für ein Protein mit FMDH-Aktivität kodieren, sowie deren Anwendung.
SG48175A1 (en) 1989-07-25 1998-04-17 Smithkline Beecham Biolog Novel antigens and method for their preparation
GB9007024D0 (en) 1990-03-29 1990-05-30 Imperial College Novel vaccine
RU2160120C2 (ru) * 1992-05-23 2000-12-10 Смитклайн Бичам Байолоджикалс С.А. Комбинированная вакцина на основе поверхностного антигена вируса гепатита в, способ ее получения и способ предупреждения инфекции гепатита в у человека

Also Published As

Publication number Publication date
BRPI9712917B8 (pt) 2021-05-25
DK1240905T5 (da) 2010-01-11
CO4910171A1 (es) 2000-04-24
DK1240905T3 (da) 2005-07-18
CZ164099A3 (cs) 1999-10-13
EP1240905B3 (de) 2009-08-26
WO1998019702A1 (en) 1998-05-14
PL188460B1 (pl) 2005-02-28
NO2006005I2 (no) 2010-04-12
HK1050473B (en) 2006-03-03
JP2001503422A (ja) 2001-03-13
ES2240647T3 (es) 2005-10-16
CY2568B1 (en) 2008-07-02
EP0941117A1 (de) 1999-09-15
CN1236321A (zh) 1999-11-24
CZ295954B6 (cs) 2005-12-14
KR20000053092A (ko) 2000-08-25
BR9712917A (pt) 1999-12-07
NO992156D0 (no) 1999-05-04
SA98181128B1 (ar) 2006-03-25
KR100518044B1 (ko) 2005-09-30
NO320186B1 (no) 2005-11-07
CA2271008A1 (en) 1998-05-14
TW471971B (en) 2002-01-11
TR199900979T2 (xx) 1999-07-21
DE122005000046I1 (de) 2005-12-29
ES2182131T3 (es) 2003-03-01
HU224126B1 (hu) 2005-05-30
DK0941117T3 (da) 2002-11-18
DE69715031D1 (de) 2002-10-02
NO2006005I1 (no) 2006-05-08
EP0941117B1 (de) 2002-08-28
JP3980652B2 (ja) 2007-09-26
PT941117E (pt) 2002-12-31
GB9623233D0 (en) 1997-01-08
IL129530A0 (en) 2000-02-29
ES2240647T7 (es) 2010-03-31
AU5319698A (en) 1998-05-29
DE69733285D1 (de) 2005-06-16
BRPI9712917B1 (pt) 2019-12-03
SI1240905T1 (en) 2005-10-31
HUP9904287A1 (hu) 2000-04-28
DE69733285T3 (de) 2010-03-25
LU91183I2 (fr) 2005-09-20
SI0941117T1 (en) 2002-12-31
ATE295178T1 (de) 2005-05-15
HK1050473A1 (en) 2003-06-27
NZ335384A (en) 2000-10-27
HUP9904287A3 (en) 2001-05-28
HK1022638A1 (en) 2000-08-18
AU710475B2 (en) 1999-09-23
EP1240905A1 (de) 2002-09-18
DE69733285T2 (de) 2006-01-12
AR011509A1 (es) 2000-08-30
CN1130226C (zh) 2003-12-10
ZA979984B (en) 1998-07-23
ATE222773T1 (de) 2002-09-15
PL333127A1 (en) 1999-11-22
NO992156L (no) 1999-05-04
CY2407B1 (en) 2004-09-10
DE69715031T2 (de) 2003-05-08
EP1240905B1 (de) 2005-05-11
CA2271008C (en) 2008-07-22
PT1240905E (pt) 2005-09-30

Similar Documents

Publication Publication Date Title
IL129530A (en) Acellular pertussis vaccine with diphtheria and tetanus-toxoids
GB9620795D0 (en) Vaccines
GB9320597D0 (en) Improvements in and realting to vaccines
PL331424A1 (en) Antipaludian vaccine composition
GB9410922D0 (en) Vaccines
GB9626864D0 (en) Vaccine
GB9625968D0 (en) Vaccine
ZA973824B (en) Vaccines
GB9406708D0 (en) Vaccines
GB9604596D0 (en) Vaccines
GB9602617D0 (en) Vaccines
GB9626882D0 (en) Vaccines
GB9614182D0 (en) Vaccines
GB9606032D0 (en) Vaccines
GB9605229D0 (en) Vaccines
GB9604595D0 (en) Vaccines
GB9625967D0 (en) Vaccine
GB9625966D0 (en) Vaccine
GB9418057D0 (en) Vaccines
GB9418058D0 (en) Vaccines
GB9405925D0 (en) Vaccines
ZA956796B (en) Vaccines
GB9405990D0 (en) Vaccines
GB9622437D0 (en) Vaccine composition
GB9622438D0 (en) Vaccine composition

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
KB Patent renewed
EXP Patent expired